Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Jubilant, Novavax Enter COVID-19 Vaccine Partnership | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Jubilant, Novavax Enter COVID-19 Vaccine Partnership

Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Jubilant HollisterStier LLC, a wholly owned subsidiary of Jubilant Pharma Limited, has entered into a non-exclusive manufacturing agreement with Novavax, a biotechnology company developing next-generation vaccines for serious infectious diseases, to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373. Under the terms of the agreement, Jubilant HollisterStier’s Spokane, WA facility has begun production activities of NVX-CoV2373 final drug product intended for commercial distribution in the U.S.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics